Find out what couples, families, and women should know after President Trump announced a deal to lower fertility drug prices.

Drugmaker EMD Serono will reduce the cost of a common fertility medication through a deal struck with the Trump administration, President Donald Trump said Thursday while also unveiling new federal guidance he said will encourage employers to offer fertility coverage.

Rather than placing more limits on medication abortion, the scientific evidence points in a completely different direction.

Self-administration of rozanolixizumab, a neonatal Fc receptor blocker (FcRn) indicated for generalized myasthenia gravis, was not only 100% successfully self-administered subcutaneously in a new study, but patients preferred the manual push method of medication delivery, according to the results published in Journal of Neurology.1

The biotechnology company said that it has launched AmgenNow, a new direct-to-patient program, starting with its drug Repatha.